Long-term angiotensin II (ANG II) infusion significantly increases ANG II levels in the kidney through two major mechanisms: AT1 receptor-mediated augmentation of angiotensinogen (AGT) expression and uptake of circulating ANG II by the proximal tubules. However, it is not known whether intracellular ANG II stimulates AGT expression in the proximal tubule. In the present study, we overexpressed an intracellular cyan fluorescent ANG II fusion protein (Ad-sglt2-ECFP/ANG II) selectively in the proximal tubule of rats and mice using the sodium and glucose cotransporter 2 (sglt2) promoter. AGT mRNA and protein expression in the renal cortex and 24-h urinary AGT excretion were determined 4 wk following overexpression of ECFP/ANG II in the proximal tubule. Systolic blood pressure was significantly increased with a small antinatriuretic effect in rats and mice with proximal tubule-selective expression of ECFP/ANG II (P Ͻ 0.01). AGT mRNA and protein expression in the cortex were increased by Ͼ1.5-fold and 61 Ϯ 16% (P Ͻ 0.05), whereas urinary AGT excretion was increased from 48.7 Ϯ 5.7 (n ϭ 13) to 102 Ϯ 13.5 (n ϭ 13) ng/24 h (P Ͻ 0.05). However, plasma AGT, renin activity, and ANG II levels remained unaltered by ECFP/ANG II. The increased AGT mRNA and protein expressions in the cortex by ECFP/ANG II were blocked in AT1a-knockout (KO) mice. Studies in cultured mouse proximal tubule cells demonstrated involvement of AT1a receptor/MAP kinases/NF-B signaling pathways. These results indicate that intracellular ANG II stimulates AGT expression in the proximal tubules, leading to increased AGT formation and secretion into the tubular fluid, which contributes to ANG II-dependent hypertension.angiotensin II; angiotensinogen; kidney; NF-B; proximal tubule THE IMPORTANT ROLE OF THE renin-angiotensin system (RAS), especially its major effector peptide, angiotensin II (ANG II), in the development and maintenance of hypertension has been well established in all ANG II-dependent hypertension models, including two-kidney, one-clip (2K1C) (5, 30, 46), Ren-2 gene transgenic (40,42,59), and ANG II-infused animals (7,56,61,63). One important and consistent feature of these ANG II-dependent hypertension models is that ANG II levels in the kidneys are increased to a greater extent than can be explained on the basis of elevated plasma ANG II which suppresses renin expression in the juxtaglomerular apparatus (JGA) of the kidney (12,29,44,61). The mechanisms underlying this phenomenon remain incompletely understood. Currently, there are at least two potential mechanisms contributing to augmentation of ANG II levels in the kidney: AT 1 receptor-mediated angiotensinogen (AGT) expression and uptake of circulating ANG II by the proximal tubules. We and others have shown that circulating ANG II or systemically infused ANG II is taken up and accumulated in the proximal tubule of the kidney, including endosomal, mitochondrial, and nuclear compartments (1,15,29,47,61). The uptake of circulating ANG II by the proximal tubule of the kidney appears to be med...